Barend Mons

Last updated

Barend Mons
Barend4.jpg
Born1957 (age 66–67)
The Hague, Netherlands
Known for
Scientific career
Institutions
Thesis Intra erythrocytic differentiation of Plasmodium Berghei  (1986)
Websitewww.go-fair.org; www.gofairfoundation.org

Barend Mons (born 1957, The Hague) is a molecular biologist by training and a leading FAIR data specialist. The first decade of his scientific career he spent on fundamental research on malaria parasites and later on translational research for malaria vaccines. In the year 2000 he switched to advanced data stewardship and (biological) systems analytics. He is currently a professor in Leiden and most known for innovations in scholarly collaboration, especially nanopublications, knowledge graph based discovery and most recently the FAIR data initiative and GO FAIR. Since 2012 he is a Professor in biosemantics in the Department of Human Genetics at the Leiden University Medical Center (LUMC) in The Netherlands. [1] [2] [3] In 2015 Barend was appointed chair of the High Level Expert Group on the European Open Science Cloud. Since 2017 Barend is heading the International Support and Coordination office of the GO FAIR initiative. He is also the elected president of CODATA, the standing committee on research data related issues of the International Science Council. Barend is a member of the Netherlands Academy of Technology and Innovation(ACTI). He is also the European representative in the Board on Research Data and Information (BRDI) of the National Academies of Science for engineering and medicine in the USA. Barend is a frequent keynote speaker about FAIR and open science around the world, and participates in various national and international boards.

Contents

Education

Mons was awarded a Masters (1981 Cum Laude) and a PhD (1986) from Leiden University on cellular and molecular biology of the malaria parasite Plasmodium berghei , [4] and has worked for more than ten years on the genetic differentiation of malaria parasites and vaccine research, [5] [6] [7] [8] publishing over 45 research articles. [1] After switching to biosemantics he published some 80 papers on this area, many of them highly cited. [9]

Past career

In 1993 Mons joined the European Commission as a Seconded National Expert with the task to develop and support international scientific networks, especially with developing countries as partners. While at the EC, in the early days of the internet, he pioneered one of the first electronic interactive communication systems for science networking with developing countries, SHARED, for which he started to (co-)design thesaurus-based concept extraction technologies in order to match across languages and jargon. From 1996 to 1999 he served the Netherlands Organization for Scientific Research (The National Research Council, NWO) as a senior advisor on International Health Research. After leaving NWO he co-founded the SME Collexis B.V. (later acquired by Elsevier Science) and also started the first Biosemantics Group at the Erasmus Medical Center in Rotterdam. In addition to his research and teaching responsibilities, Mons has remained involved in international scientific management and networking at various levels. After leaving Collexis in 2005 he co-founded Knewco, Inc. in 2006, and more recently, part of his intellectual legacy was the basis for the founding of the successful SME Euretos, focused on advanced machine learning over machine readable data, now also being used for academic research purposes. From 2008, Barend served as a scientific director of the Netherlands Bioinformatics Centre, the predecessor of the current Dutch Techcentre for the Life Sciences (DTL), which he co-founded. DTL was one of the initial supporters of the FAIR data concept. He served as the ‘Integrator for Life Sciences’ in the Netherlands e- Science Center from its inception till 2016, where he was one of the initiators of an early white paper: Data-Stewardship in the Big Data Era: Taking Care of Data (2013). Barend was one of the designers and coordinators of the transformational Innovative Medicines Initiative (IMI) project known as Open PHACTS, [10] [11] pioneering the use of semantic technologies, nanopublications and micro-attributions in pharmaceutical biomedical research. From 2013 to 2015 he acted as Head of Node of the Dutch Node in ELIXIR. In 2014, he initiated the FAIR Data initiative [12] and in 2015 he was appointed Chair of the High Level Expert Group for the European Open Science Cloud. From 2017-2020, he served as the scientific director of the International Support and Coordination Office in the GO FAIR initiative.

Present activities

His present research activities in LUMC mainly focus on open science, and international knowledge sharing and networking. A more specific aim in his research group is to realise a new form of computer-assisted distributed annotation and learning and on-line knowledge discovery, based on the semantic technologies that his research yielded over the years, including nanopublications. Since 2017 his main task has been to set up and lead the international initiative Global Open FAIR (GO FAIR), which is aimed at implementing the FAIR guiding principles in order to create an ‘Internet for Machines’ to support open science and innovation. In his capacity of president of CODATA, he works with an international executive committee to support open science data policies and practices. Barend published the handbook Data Stewardship for Open Science, Implementing FAIR Principles, which is functionally integrated with an on line stewardship wizard. He is currently the Scientific Director of the GO FAIR Foundation.[ citation needed ]

Related Research Articles

Since October 2018, the Center for Global Infectious Disease Research has been part of the Seattle Children's Research Institute. At the time of the merger, CID Research had 166 scientists. Its mission was to eliminate the world's most devastating infectious diseases through leadership in scientific discovery. The organization's research labs were in the South Lake Union area of Seattle, WA. The institute's research focused on four areas of infectious disease: HIV/AIDS, malaria, tuberculosis (TB), and Emerging & Neglected Diseases (END) like African sleeping sickness, leishmaniasis, Chagas disease, and toxoplasmosis. CID Research was engaged in early stages of the scientific pipeline including bench science and malaria clinical trials and has expertise in immunology, vaccinology, and drug discovery.

<span class="mw-page-title-main">Jan Velterop</span>

Johannes (Jan) Josephus Marinus Velterop is a science publisher.

<i>Plasmodium berghei</i> Single celled parasite, rodent malaria

Plasmodium berghei is a single-celled parasite causing rodent malaria. It is in the Plasmodium subgenus Vinckeia.

<span class="mw-page-title-main">Carole Goble</span> British computer scientist

Carole Anne Goble, is a British academic who is Professor of Computer Science at the University of Manchester. She is principal investigator (PI) of the myGrid, BioCatalogue and myExperiment projects and co-leads the Information Management Group (IMG) with Norman Paton.

WikiProfessional was an attempt to create a web-based research environment for semantic searching, providing an intuitive tool for analyzing and relating concepts.

Malaria vaccines are vaccines that prevent malaria, a mosquito-borne infectious disease which annually affects an estimated 247 million people worldwide and causes 619,000 deaths. The first approved vaccine for malaria is RTS,S, known by the brand name Mosquirix. As of April 2023, the vaccine has been given to 1.5 million children living in areas with moderate-to-high malaria transmission. It requires at least three doses in infants by age 2, and a fourth dose extends the protection for another 1–2 years. The vaccine reduces hospital admissions from severe malaria by around 30%.

ChemSpider is a freely accessible online database of chemicals owned by the Royal Society of Chemistry. It contains information on more than 100 million molecules from over 270 data sources, each of them receiving a unique identifier called ChemSpider Identifier.

<span class="mw-page-title-main">Antony John Williams</span> British chemist

Antony John Williams is a British chemist and expert in the fields of both nuclear magnetic resonance (NMR) spectroscopy and cheminformatics at the United States Environmental Protection Agency. He is the founder of the ChemSpider website that was purchased by the Royal Society of Chemistry in May 2009. He is a science blogger and an author.

Gerhard F. Ecker is an Austrian medicinal chemist and expert in the fields of Pharmacoinformatics at the University of Vienna, where he is the Professor for Pharmacoinformatics and Head of the Pharmacoinformatics Research Group at the Department of Medicinal Chemistry. He also coordinates the research focus "Computational Life Sciences" of the Faculty of Life Sciences.

Open scientific data or open research data is a type of open data focused on publishing observations and results of scientific activities available for anyone to analyze and reuse. A major purpose of the drive for open data is to allow the verification of scientific claims, by allowing others to look at the reproducibility of results, and to allow data from many sources to be integrated to give new knowledge.

The Netherlands Bioinformatics Centre or NBIC (2003-2013) was a Dutch, government-funded organization, that coordinated all academic work on bioinformatics in the Netherlands. NBIC consisted of programs for research (BioRange), for education (BioWise), and for support (BioAssist). NBIC partners are all Dutch universities and university hospitals, and some commercial entities. The NBIC central office was hosted by the Center for Molecular and Biomolecular Informatics (CMBI) at the Radboud University Nijmegen Medical Centre.

The term microattribution is defined as "giving database accessions the same citation conventions and indices that journal articles currently enjoy". In the sense that the purpose of precise attribution is to extend the scholarly convention of giving citation credit, the provenance of a piece of scholarship is recognized to give credit and priority to a preceding author. Microattribution is thus defined as "a scholarly contribution smaller than a journal article being ascribed to a particular author" or a small scholarly contribution being ascribed to a particular author. Since data accessions can describe contributions that can vastly exceed research articles in size and quality, quantum attribution or precise citation might be better terms.

Open PHACTS was a European initiative public–private partnership between academia, publishers, enterprises, pharmaceutical companies and other organisations working to enable better, cheaper and faster drug discovery. It has been funded by the Innovative Medicines Initiative, selected as part of three projects to "design methods for common standards and sharing of data for more efficient drug development and patient treatment in the future".

Identifiers.org is a project providing stable and perennial identifiers for data records used in the Life Sciences. The identifiers are provided in the form of Uniform Resource Identifiers (URIs). Identifiers.org is also a resolving system, that relies on collections listed in the MIRIAM Registry to provide direct access to different instances of the identified records.

Sanaria is a biotechnology company developing vaccines protective against malaria and other infectious diseases as well as related products for use in malaria research. Sanaria's vaccines are based on the use of the sporozoite (SPZ) stage of the malaria parasite, Plasmodium, as an immunogen, and as a platform technology for liver-vectored gene delivery. SPZ are normally introduced into humans by mosquito bite where they migrate to the liver and further develop to liver stages, and eventually back into the blood stream where the parasite infects red blood cells (RBC) and causes malaria. Plasmodium falciparum is the species responsible for more than 95% deaths caused by malaria. The WHO estimates there were 249 million clinical cases and 608,000 deaths in 2022 alone.

DisGeNET is a discovery platform designed to address a variety of questions concerning the genetic underpinning of human diseases. DisGeNET is one of the largest and comprehensive repositories of human gene-disease associations (GDAs) currently available. It also offers a set of bioinformatic tools to facilitate the analysis of these data by different user profiles. It is maintained by the Integrative Biomedical Informatics (IBI) Group, of the (GRIB)-IMIM/UPF, based at the Barcelona Biomedical Research Park (PRBB), Barcelona, Spain.

Ruth Sonntag Nussenzweig was an Austrian-Brazilian immunologist specializing in the development of malaria vaccines. In a career spanning over 60 years, she was primarily affiliated with New York University (NYU). She served as C.V. Starr Professor of Medical and Molecular Parasitology at Langone Medical Center, Research Professor at the NYU Department of Pathology, and finally Professor Emerita of Microbiology and Pathology at the NYU Department of Microbiology.

<span class="mw-page-title-main">FAIR data</span> Data compliant with the terms of the FAIR Data Principles

FAIR data are data which meet principles of findability, accessibility, interoperability, and reusability (FAIR). The acronym and principles were defined in a March 2016 paper in the journal Scientific Data by a consortium of scientists and organizations.

<span class="mw-page-title-main">Christine L. Mummery</span>

Christine L. Mummery (1953) is an appointed professor of Developmental Biology at Leiden University and the head of the Department of Anatomy and Embryology at Leiden University Medical Center in the Netherlands.

<span class="mw-page-title-main">Xiaogang Ma</span> Chinese computer scientist

Xiaogang Ma or Marshall Ma is a Chinese data science and geoinformatics researcher at the University of Idaho (UI), United States. He is an associate professor in the department of computer science at UI, and also affiliates with the department of earth and spatial sciences and several research institutes and centers at the university.

References

  1. 1 2 Barend Mons publications indexed by Google Scholar
  2. ↑ Barend Mons's publications indexed by the Scopus bibliographic database. (subscription required)
  3. ↑ Barend Mons publications from Europe PubMed Central
  4. ↑ Mons, B. (1986). "Intra erythrocytic differentiation of Plasmodium berghei". Acta Leidensia. 54: 1–124. PMID   3538746.
  5. ↑ Mons, B.; Klasen, E.; Van Kessel, R.; Nchinda, T. (1998). "Biomedicine: Partnership Between South and North Crystallizes Around Malaria". Science. 279 (5350): 498–499. Bibcode:1998Sci...279..498M. doi:10.1126/science.279.5350.498. PMID   9454348. S2CID   42396771.
  6. ↑ Bruno, J. M.; Feachem, R.; Godal, T.; Nchinda, T.; Ogilvie, B.; Mons, B.; Mshana, R.; Radda, G.; Samba, E.; Schwartz, M.; Varmus, H.; Diallo, S.; Doumbo, O.; Greenwood, B.; Kilama, W.; Miller, L. H.; Da Silva, L. P. (1997). "The spirit of Dakar: A call for action on malaria". Nature. 386 (6625): 541. Bibcode:1997Natur.386..541.. doi: 10.1038/386541a0 . PMID   9121571. S2CID   4265060.
  7. ↑ Mons, B. (March 1997). "The problem of multiplicity in malaria vaccine development". Annals of Tropical Medicine & Parasitology. 91 (sup1): S55–S58. doi:10.1080/00034983.1997.11813239.
  8. ↑ Mäkelä, H; Mons, B; Roumiantzeff, M; Wigzell, H (May 1996). "Report of the Expert Panel X Animals models for vaccines to prevent infectious diseases". Vaccine. 14 (7): 717–732. doi:10.1016/s0264-410x(96)90052-3. PMID   8799983.
  9. ↑ "Barend Mons".
  10. ↑ Williams, Antony J.; Harland, Lee; Groth, Paul; Pettifer, Stephen; Chichester, Christine; Willighagen, Egon L.; Evelo, Chris T.; Blomberg, Niklas; Ecker, Gerhard; Goble, Carole; Mons, Barend (November 2012). "Open PHACTS: semantic interoperability for drug discovery". Drug Discovery Today. 17 (21–22): 1188–1198. doi: 10.1016/j.drudis.2012.05.016 . PMID   22683805.
  11. ↑ Mons, Barend; van Haagen, Herman; Chichester, Christine; Hoen, Peter-Bram 't; den Dunnen, Johan T; van Ommen, Gertjan; van Mulligen, Erik; Singh, Bharat; Hooft, Rob; Roos, Marco; Hammond, Joel; Kiesel, Bruce; Giardine, Belinda; Velterop, Jan; Groth, Paul; Schultes, Erik (April 2011). "The value of data". Nature Genetics. 43 (4): 281–283. doi: 10.1038/ng0411-281 . PMID   21445068. S2CID   20891055.
  12. ↑ Wilkinson, Mark D.; Dumontier, Michel; Aalbersberg, IJsbrand Jan; Appleton, Gabrielle; Axton, Myles; Baak, Arie; Blomberg, Niklas; Boiten, Jan-Willem; da Silva Santos, Luiz Bonino; Bourne, Philip E.; Bouwman, Jildau; Brookes, Anthony J.; Clark, Tim; Crosas, Mercè; Dillo, Ingrid; Dumon, Olivier; Edmunds, Scott; Evelo, Chris T.; Finkers, Richard; Gonzalez-Beltran, Alejandra; Gray, Alasdair J. G.; Groth, Paul; Goble, Carole; Grethe, Jeffrey S.; Heringa, Jaap; ’t Hoen, Peter A. C.; Hooft, Rob; Kuhn, Tobias; Kok, Ruben; Kok, Joost; Lusher, Scott J.; Martone, Maryann E.; Mons, Albert; Packer, Abel L.; Persson, Bengt; Rocca-Serra, Philippe; Roos, Marco; van Schaik, Rene; Sansone, Susanna-Assunta; Schultes, Erik; Sengstag, Thierry; Slater, Ted; Strawn, George; Swertz, Morris A.; Thompson, Mark; van der Lei, Johan; van Mulligen, Erik; Velterop, Jan; Waagmeester, Andra; Wittenburg, Peter; Wolstencroft, Katherine; Zhao, Jun; Mons, Barend (15 March 2016). "The FAIR Guiding Principles for scientific data management and stewardship". Scientific Data. 3 (1): 160018. Bibcode:2016NatSD...360018W. doi:10.1038/sdata.2016.18. PMC   4792175 . PMID   26978244.
This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.